Company · Ownership research

VERTEX PHARMACEUTICALS INC / MA VRTX

CIK 0000875320

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 59 rows; the complete set is available through the API.

Insider filings on file run through Oct 22, 2026.

Insider purchases & sales

Purchased: $5.84M
Sold: $294.93M

Nov 1, 2023 – Oct 22, 2026
Available records · partial months are marked ·

Insiders in this window

202410 of 30 preview events · 59 available in 2024

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 15, 2024	ALTSHULER DAVID EVP, Chief Scientific Officer	Sale10b5-1 footnote	$7.18K 15 shares sold	0.06% sold Direct holding	▾
Nov 11, 2024	WAGNER CHARLES F JR EVP & Chief Financial Officer	Sale10b5-1 footnote	$1.55M 3,000 shares sold	6.36% sold Direct holding	▾
Nov 8, 2024	Kewalramani Reshma CEO & President · Director	Sale10b5-1 footnote	$7.83M 15,198 shares sold	16.71% sold Direct holding	▾
Oct 2, 2024	Biller Jonathan EVP and Chief Legal Officer	Sale10b5-1 footnote	$461.20K 999 shares sold	5.66% sold Direct holding	▾
Aug 30, 2024	LEIDEN JEFFREY M Executive Chairman · Director	Sale10b5-1 footnote	$1.89M 3,784 shares sold	27.46% sold Direct holding	▾
Aug 30, 2024	Bhatia Sangeeta N. Director	Sale10b5-1 footnote	$323.00K 646 shares sold	12.71% sold Direct holding	▾
Aug 8, 2024	Bhatia Sangeeta N. Director	Sale10b5-1 footnote	$602.45K 1,292 shares sold	22.56% sold Direct holding	▾
Aug 7, 2024	Bozic Carmen EVP and CMO	Sale10b5-1 footnote	$1.09M 2,280 shares sold	8.93% sold Direct holding	▾
Aug 1, 2024	SACHS BRUCE I Director	Sale10b5-1 footnote	$2.69M 5,295 shares sold	11.69% sold Direct holding	▾
Jul 30, 2024	Kewalramani Reshma CEO & President · Director	Sale10b5-1 footnote	$7.68M 15,202 shares sold	14.32% sold Direct holding	▾

Showing 30 / 59 record groups in 2024. The complete set is available through the API.

VERTEX PHARMACEUTICALS INC / MA · VRTX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 59 purchase / sale groups and 30 of 95 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"VRTX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.